(Q40232391)

18 September 2017

Dimerization of Laforin is required for its optimal phosphatase activity, regulation of GSK3beta phosphorylation, and Wnt signaling (English)

1 reference

Epilepsy, progressive myoclonic epilepsy, type 2 gene alpha

18 September 2017

1 reference

GOA release 2020-03-11

1 reference

Yan Liu

1

1 reference

18 September 2017

Yin Wang

2

1 reference

18 September 2017

Cindy Wu

3

1 reference

18 September 2017

Yang Liu

4

1 reference

18 September 2017

Pan Zheng

5

1 reference

18 September 2017

language of work or name

English

0 references

publication date

12 September 2006

1 reference

Journal of Biological Chemistry

18 September 2017

1 reference

18 September 2017

281

1 reference

18 September 2017

34768-34774

1 reference

18 September 2017

46

1 reference

Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy

18 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Mutations in NHLRC1 cause progressive myoclonus epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Myoclonic epilepsy with lafora bodies. Some ultrastructural, histochemical, and biochemical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A) causes Lafora progressive myoclonus epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

A high-frequency polymorphism in exon 6 of the CD45 tyrosine phosphatase gene (PTPRC) resulting in altered isoform expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

A structural basis for 14-3-3sigma functional specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607778200

21 January 2018

Identifiers

DOI

10.1074/JBC.M607778200

1 reference

18 September 2017

1 reference